Lam Research【L1RC34】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
ブラジル
BOV
Lam Research Corp (L1RC34) 銘柄情報

Lam Research Corp (L1RC34)

9.55

-0.09

(-0.93%)

終了 11月25日 5:55AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

9.55

買値

0.00

売値

0.00

出来高

743

9.49 日の範囲 9.72

7.752 52 週間の範囲 14.287

時価総額

前日終値

9.64

始値

9.58

時刻

最終取引時間

財務取引量

R$ 7,091

VWAP

9.544

平均取引量 (3 か月)

31,975

発行済株式数

130,741,000

配当利回り

0.88%

PER

2.48

1 株当たり利益 (EPS)

29.28

歳入

14.91B

純利益

3.83B

セクター

Special Industry Machy, Nec

業界

Special Industry Machy, Nec

ウェブサイト

www.lamresearch.com

本社

Wilmington, Delaware, USA

設立

-

Lam Research Corp is listed in the Special Industry Machy sector of the ボベスパ (ブラジル) with ticker L1RC34. The last closing price for Lam Research was R$9.64. Over the last year, Lam Research shares have traded in a share price range of R$ 7.752 to R$ 14.287.

Lam Research currently has 130,741,000 shares in issue. The market capitalisation of Lam Research is R$1.26 billion. Lam Research has a price to earnings ratio (PE ratio) of 2.48.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.25	2.68817204301	9.3	9.72	9.09	12260	9.36585656	DR
4	-0.45	-4.5	10	10.38	9.09	59251	9.82552243	DR
12	-1.45000016	-13.1818194446	11.00000016	11.06	8.96200013	31975	9.7971406	DR
26	-1.64700017	-14.7092984281	11.19700017	14.28700021	8.96200013	16483	9.9434396	DR
52	1.54899988	19.3600781998	8.00100012	14.28700021	7.75200012	9317	9.94922639	DR
156	1.50627204	18.7260440369	8.04372796	14.28700021	3.66079998	4063	9.72410012	DR
260	6.49956802	213.070413063	3.05043198	14.28700021	2.17315999	2981	9.55780783	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AMER3Americanas SA	R$ 8.70 (14.78%)	13.15M
OIBR3Oi	R$ 1.46 (9.77%)	11.56M
IFCM3Infracommerce Caxaas S.A.	R$ 0.12 (9.09%)	1.92M
HETA4Hercules SA Fabrica De Talheres	R$ 6.98 (8.39%)	200
TECN3Technos SA	R$ 5.74 (8.30%)	333.8k
MERC4Mercantil Financeria S.A. - Credito Financiamento e Investimento	R$ 8.90 (-12.66%)	6.5k
VSTE3Veste S.A. Estilo	R$ 8.42 (-8.97%)	5.73k
FRIO3Metalfrio Solutions Sa	R$ 145.50 (-7.91%)	1.3k
AMBP3Ambipar Participacoes e Empreendimentos SA	R$ 170.00 (-7.61%)	139.2k
ONCO3Oncoclinicas Brasil Servicos Medico	R$ 3.33 (-7.24%)	5.29M
PETR4Petroleo Brasileiro S.A. Petrobras	R$ 39.42 (3.98%)	85.23M
HAPV3Hapvida Participacoes Investimento SA	R$ 2.98 (3.47%)	56.29M
COGN3CognaEducacao SA	R$ 1.39 (5.30%)	35.3M
RAIZ4Raizen S.A	R$ 2.60 (7.00%)	34.25M
CVCB3CVC Brasil Operadora E Agencia De Viagens SA	R$ 2.53 (5.42%)	34.17M

quester614

quester614 6分前

Don't know about that. This guy is an International schiester. Visit that link and see all the different countries he operates in.

https://investorshub.advfn.com/uimage/uploads/2024/11/24/wnlumScreenshot_2024-11-24_11.59.20_AM.png
https://investorshub.advfn.com/

xoom

Bigbang, I have noticed, over the last years, no matter what answer any long term shareholder provides, you are never satisfied . So I am just going to ignore your question.

dinogreeves

dinogreeves 6分前

Euro, this one is a hold for dear life.

monocle

monocle 7分前

Still 4.2 million class b shares yet to convert, maybe that explains part of the discrepancy?

dennisdave

dennisdave 8分前

Yes, all the new programs are so exciting Someone is upset here boohoo. Is someone having a bad weekend? Its called panic and shorts are unable to deal with new reality.
Will bring this back up in Spring when it is clear that the MAA is going nowhere.
So you are disregarding the fact

BDEZ

Yup, i'm reading "Crossfire" now. Marrs said we live in a banana republic.

newfinish

newfinish 11分前

I hope this thing will start to move soon

weedtrader420

weedtrader420 11分前

XRP🌉🌉⛓️

semi_infinite

semi_infinite 12分前

Nuro.ai - See supervised nuro.ai Prius around ofter in the MV area. Apparently, they are now pilot testing the real deal on MV roads. This was from last week in an area of MV I am not familiar with. No windows, no dirver, just sensors.

https://www.youtube.com/watch?v=JK7G-7Arf4M&t=

Fanniefreddieforever

Fanniefreddieforever 13分前

Navy, it’s been a while. We are GOLDEN indeed. I dare anyone who dispute Bessent’s positive views on the GSEs.

Investor Will

Investor Will 13分前

Hi Jake,

Are you suggesting a cash holding level of 55.3%? If so how have you calculated that?

I do understand the forward returns based on the figures.

Thanks

Will

backtoreality

backtoreality 13分前

What sux is these players that buy 10's of millions of shares in the trips will flip out simultaneously. Screwing the Etrader Swing rookies.Thats why the OTC sux. Until the greedy pigs relax, the otc will remain in the sorry state that its in.

dewophile

dewophile 13分前

The odd thing is that there were several failures in this space of drugs that clearly have good antiviral activity. The analyst just didn’t push back. I’m fact zelicapavir itself failed in the standard risk RSVP study. The most notable failure was Lumicitabine which JNJ picked up from Alios which ha

BDEZ

Rep Jim Hill 2018 networth 7 mil, 2022 17 mil.....

tschussmann1

tschussmann1 15分前

Some good discussion on the Rett trial design and lack of statistical significance for a treatment that likely really does "work". As such, I "upvote" good arguments on both sides. Now, from both the company's and investor's perspective the key is: MAA filing for Alzheimer's in Q4 2024. Delivery

BDEZ

Rep Gottheimer 2018 networth 9 mil, 2022 32 mil.....

makingmoneyx3

makingmoneyx3 16分前

I'm holding all my shares. TXTM to the moon baby!

BDEZ

Ted Cruz, 2018 networth 3.5 mil, 2022 6.7 mil.....

Disquisition

Disquisition 17分前

Cry even harder than that! I know you can do it! Let the LIBERAL TEARS flow bwahahahahahahahahah!!!!

HILARIOUS seeing all the PISSED-OFF socialists MELTING DOWN in the light of REALITY as their WORST NIGHTMARE is set to begin on January 20th 😃

Keep the CRYING

BDEZ

OK Senator Markwayne Mullin’s Net Worth QUADRUPLED Between 2018-2022 From $12m -> $63m

https://x.com/WallStreetApes/status/1860709449431724308

flipper44

flipper44 19分前

Are you seriously suggesting an IND between those two (assumed) approved therapies would not be accepted, and that they’d worry about that, if, for instance, Merck and NWBO have already worked months designing the trials. Seriously? You couldn’t say that with a straight face.

(Wheth

dangriff

dangriff 20分前

I dont want an update. I want contracts to be signed and pr’s issued. And buildings built. Petroleum flowing. And additives mixed…..

weedtrader420

weedtrader420 22分前

thirdcoast

thirdcoast 23分前

https://www.youtube.com/watch?v=kVcpc0iL2aQ

kayak_wench

kayak_wench 23分前

No one is talking about releasing shares, and the company hasn’t done that other than to pay salaries for many years. Thankfully we became profitable enough to even stop that. I was referring to past decisions made years ago to reinforce how loan adverse our CEO is.

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約